Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy

Kidney International

Volumn 53, Issue 4, 1998, Pages 1002-1006

  Jacobsen, Peter ^b   Rossing, Kasper ^b   Rossing, Peter ^b   Tarnow, Lise ^b   Mallet, Christine ^b   Poirier, Odette ^b   Cambien, Francois ^b   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b NONE

Author keywords

ACE gene and inhibition; Albuminuria; Diabetic nephropathy; Glomerular filtration rate; IDDM; Polymorphism in ACE gene; Progression of diabetes; Proteinuria

Indexed keywords

ALBUMIN; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; FUROSEMIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEINURIA;

EID: 0031958914     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00847.x     Document Type: Article

References (30)

1. WATKINS PJ, BLAINEY JD, BREWER DB, FITZGERALD MG, MALINS JM, O'SULLIVAN DJ, PINTO J: The natural history of diabetic renal disease. A follow-up study of scries of renal biopsies. Q J Med 41:437-456, 1972
2. ROSSING P, HOMMEL E, SMIDT UM, PARVING H-H; Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715-719, 1993
3. LEWIS E, HUNSICKER L, BAIN R, RHODE R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
4. ROSSING P, HOMMEL E, SMIDT UM, PARVING H-H: Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37:511-516, 1994
5. APPERLOO AJ, DE ZEEUW D, DE JONG PE: Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidnet Int 45(Suppl 45):S174-S178, 1994
6. APPERLOO AJ, DE ZEEUW D, DE JONG PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 51:793-797, 1997
7. VAN ESSEN GG, RENSMA PL, DE ZEEUW D, SLUITER WJ, SCHEFFER H. APPERLOO AJ, DE JONG PE: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347:94-95, 1996
8. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R, KAWAGUCHI Y, KUBO H, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
9. MORIYAMA T, KITAMURA H, OCHI S, IZUMI M, YOKOYAMA K, YAMAUCHI A, UEDA N, KAMADA T, IMAI E: Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 6:1674-1678, 1995
10. SCHMIDT A, HAAS M, YLMAS N, MAYER G, AUSTRIAN STUDY GROUP OF ENALAPRIL IN RENAL DISEASE: Angiotensin converting enzyme (ACE) gene polymorphism determines the renal response to ACE inhibition in patients with proteinuric kidney disease. (abstract) J Am Soc Nephrol 7:1398, 1996
11. PARVING H-H, JACOBSEN P, TARNOW L, ROSSING P, LECERE L, POIRIER O, CAMBIEN F: Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: Observational follow up study. Br Med J 313:591-594, 1996
12. YOSHIDA H, KURIYAMA S, ATSUMI Y, TOMONARI H, MITARAI T, HAMAGUCHI A, KUBO H, KAWAGUCHI Y, KON V, MATSUOKA K, ICHIKAWA I, SAKAI O: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664, 1996
13. HARDEN PN, GEDDES C, ROWE PA, MCILROY JH, BOULTON-JONES M, ROGERS S, JUNOR BJR, BRIGGS JD, CONNELL JMC. JARDINE AG: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542, 1995
14. HUNLEY TE, JULIAN BA, PHILIPS JA, SUMMAR ML, YOSHIDA H, HORN RG, BROWN NJ, FOGO A, ICHIKAWA I, KON V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
15. TARNOW L, CAMBIEN F, ROSSING P, NIELSEN FS, HANSEN BV, LECERF L. POIRIER O, DANILOV S, PARVING H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
16. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl-carboxy peptidose 1). Nucl Acids Res 20:1433-1433, 1992
17. EVANS A, POIRIER O, KEE F, LECERF L, MCCRUM E, FALCONER T, CRANE J. O'ROUKE DF, CAMBIEN F: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 87:211-214, 1994
18. FELDT-RASMUSSEN U, DINESEN B, DECKERT M: Enzyme immunoassay: An improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
19. BRÖCHNER-MORTENSEN J, RÖDBRO P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36:35-45, 1976
20. FERRANNINI E, BUZZIGOLI G, BONADONNA R, GIORICO MA, OLEGGINI M, GRAZIADEI L, PEDRINELLI R, BRANDI L, BEVILACOUA S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
21. THE EUCLID STUDY GROUP CO-ORDINATING CENTRE F: Differences in albumin excretion rate response to lisinopril by ACE genotype in insulin dependent diabetes (IDDM). (abstract) Diabetologia 39:A60, 1996
22. VAN DER KLEIJ, FGH, NAVIS GJ, SCHEFFER H, DE ZEEUW D, DE JONG PE: ACE gene polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients. (abstract) J Am Soc Nephrol 7:1326-A0400, 1996
23. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
24. YOSHIDA H, KON V, ICHIKAWA I: Polymorphisms of the reninangiotensin system genes in progressive renal diseases. Kidney Int 50:732-744, 1996
25. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25: 1266-1269, 1995
26. UEDA S, MEREDITH PA, MORTON JJ, CONNELL JMC, ELLIOTT HL: The response to enalapril is influenced by variation at the angiotensin-converting enzyme gene locus in humans. Kidney Int (in press)
27. MORELLI E, LOON N, MEYER TW, PETERS W, MYERS BD: Effects of converting-enzyme inhibition on barrier function in diabetic glumerulopathy. Diabetes 39:76-82, 1990
28. GANSEVOORT RT, DE ZEEUW D, DE JONG PF: Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int 44:579-584, 1993
29. HEEG JE, DE JONG PE, VAN DEN HEM GK, DE ZEEUW D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36:272-279, 1989
30. ROSSING P, HOMMEL E, SMIDT UM, PARVING H-H: Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45(Suppl 45):S145-S149, 1994